Insider screener

Period: 12 months + Add filter
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

60,176 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

60,176 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

60,176 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

60,176 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
60,176 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
60,176 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

60,176 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
2 Mar 2026
Kidd Mark EVP, GM Data Centers & ALM
Sold on a plan
$643.62K 6,000 at 107.27
4.4%
Planned (10b5-1)
2 Mar 2026
Aboud Matt SVP, Strategy & Business Dev't
Sold at will
$636.62K 12,126 at 52.50
15.2%
Not planned
2 Mar 2026
Turtle Cameron Chief Executive Officer
Sold on a plan 2×
$632.87K 15,000 at 42.19
2.3%
Planned (10b5-1)
2 Mar 2026
Grabscheid Eduard CHIEF FINANCIAL OFFICER
Sold at will
$627.91K 15,639 at 40.15
6.1%
Not planned
2 Mar 2026
Dean Lia Pres, Banking & Prem. Products
Sold on a plan
$627.24K 3,284 at 191.00
4.9%
Planned (10b5-1)
2 Mar 2026
Plater Michael A Director
Sold at will
$616.56K 17,256 at 35.73
49.6%
Not planned
2 Mar 2026
Sheena Jonathan Director
Sold on a plan 4×
$614.71K 3,070 at 200.23
1.2%
Planned (10b5-1)
2 Mar 2026
Sathyanarayanan Bala EVP, Chief Human Resources Off
Sold at will
$613.64K 8,524 at 71.99
27.5%
Not planned
2 Mar 2026
GOLDSMITH MARK A See Remarks · indirect
Sold on a plan 8×
$607.78K 6,000 at 101.30
8.5%
Planned (10b5-1)
2 Mar 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 3×
$599.55K 3,000 at 199.85
2.0%
Planned (10b5-1)
2 Mar 2026
Nonko Eugene Director · indirect
Sold on a plan
$592.36K 59,202 at 10.01
4.1%
Planned (10b5-1)
2 Mar 2026
Olivan Javier Chief Operating Officer
Sold on a plan
$590.06K 926 at 637.21
5.4%
Planned (10b5-1)
2 Mar 2026
Sold on a plan 3×
$589.77K 11,000 at 53.62
70.3%
Sold half or more
2 Mar 2026
MURPHY RICHARD B VICE CHAIR,CHIEF LENDING OFC
Sold at will
$585.39K 3,979 at 147.12
9.3%
Not planned
2 Mar 2026
Sold on a plan
$583.95K 7,212 at 80.97
19.9%
Planned (10b5-1)
2 Mar 2026
Rogers James William Chief Financial Officer
Sold on a plan
$578.58K 11,414 at 50.69
8.2%
Planned (10b5-1)
2 Mar 2026
SANFILIPPO JEFFREY T Chief Executive Officer
Sold on a plan
$577.55K 7,212 at 80.08
15.1%
Planned (10b5-1)
2 Mar 2026
Sold at will
$574.17K 19,310 at 29.73
0.6%
Not planned
2 Mar 2026
Patterson Chad CHIEF COMM & PRODUCT OFFICER
Sold at will 2×
$570.80K 4,444 at 128.44
7.1%
Not planned
2 Mar 2026
Mansueto Joseph D Executive Chairman
Sold on a plan
$569.19K 3,122 at 182.32
0.0%
Planned (10b5-1)
2 Mar 2026
STETZ MATTIAS Chief Operating Officer · indirect
Sold on a plan 2×
$567.82K 28,383 at 20.01
48.8%
Planned (10b5-1)
2 Mar 2026
Mackin James P President & CEO
Sold at will
$566.99K 14,911 at 38.02
1.7%
Not planned
2 Mar 2026
Garg Pushkal EVP Chief R&D
Sold on a plan 10×
$562.59K 1,717 at 327.66
6.4%
Planned (10b5-1)
2 Mar 2026
Sold at will 3×
$559.62K 4,357 at 128.44
6.4%
Not planned
2 Mar 2026
STETZ MATTIAS Chief Operating Officer
Sold on a plan
$558.76K 28,109 at 19.88
9.7%
Planned (10b5-1)
2 Mar 2026
Currier James E Pres/CEO Aero Technologies
Sold at will
$547.73K 2,248 at 243.65
33.2%
Not planned
2 Mar 2026
Sold at will 4×
$544.02K 434,830 at 1.25
83.7%
Sold half or more
2 Mar 2026
Frost Bert A EVP, Chief Commercial Officer
Sold on a plan
$540.76K 5,102 at 105.99
5.0%
Planned (10b5-1)
2 Mar 2026
Howse Curtis See remarks
Sold on a plan
$533.69K 7,882 at 67.71
7.7%
Planned (10b5-1)
2 Mar 2026
MILLS THOMAS E IV President, C5ISR Division
Sold on a plan 8×
$525.45K 5,758 at 91.26
58.5%
Sold half or more
2 Mar 2026
Fitzgerald Kevin Joseph CSO & EVP, Head of Research
Sold on a plan 10×
$523.58K 1,598 at 327.65
6.4%
Planned (10b5-1)
2 Mar 2026
Tanguler Tolga EVP, Chief Commercial Officer
Sold at will 10×
$523.58K 1,598 at 327.65
4.2%
Not planned
2 Mar 2026
Sold on a plan
$523.44K 6,000 at 87.24
7.8%
Planned (10b5-1)
2 Mar 2026
Goff Brian Chief Executive Officer
Sold on a plan 3×
$522.87K 18,055 at 28.96
10.9%
Planned (10b5-1)
2 Mar 2026
GORDON WILLIAM B Director
Sold on a plan
$522.53K 2,500 at 209.01
4.0%
Planned (10b5-1)
2 Mar 2026
Turakhia Minang CHIEF MED/SCI OFCR EVP ADVTECH
Sold at will 3×
$517.26K 4,027 at 128.45
6.8%
Not planned
2 Mar 2026
CHEN JESSE Director
Sold at will
$516.12K 11,320 at 45.59
5.4%
Not planned
2 Mar 2026
Miln James Chief Financial Officer
Sold on a plan 6×
$515.43K 12,272 at 42.00
7.1%
Planned (10b5-1)
2 Mar 2026
Wynne Mitch S. Director
Sold at will
$506.80K 35,000 at 14.48
11.3%
Not planned
2 Mar 2026
Dier Mardi EVP and CFO
Sold at will
$505.39K 1,183 at 427.21
11.3%
Not planned
2 Mar 2026
Bought
$499.98K 8,163 at 61.25
×19
First buy on file
2 Mar 2026
Bell Ryan B President, MCM
Sold on a plan 4×
$499.84K 7,240 at 69.04
13.1%
Planned (10b5-1)
2 Mar 2026
Gollob Jared Chief Medical Officer
Sold at will 3×
$499.15K 5,613 at 88.93
4.4%
Not planned
2 Mar 2026
LEDERER JAMES P Director
Sold at will
$499.00K 5,000 at 99.80
9.9%
Not planned
2 Mar 2026
Neville Everett See Remarks
Sold on a plan
$496.64K 1,719 at 288.91
23.3%
Planned (10b5-1)
2 Mar 2026
Sajnani Sunil Chief Audit/LP Executive
Sold at will
$491.13K 18,353 at 26.76
17.7%
Not planned
2 Mar 2026
Nonko Eugene Director
Sold on a plan
$488.43K 48,801 at 10.01
5.2%
Planned (10b5-1)
2 Mar 2026
Mertz Elinor Chief Financial Officer
Sold on a plan
$487.50K 3,750 at 130.00
0.9%
Planned (10b5-1)
2 Mar 2026
Savage William Jacob Chief Medical Officer
Sold on a plan 2×
$486.07K 7,378 at 65.88
8.0%
Planned (10b5-1)
2 Mar 2026
Febbo Phillip G. Chief Scientific & Med Officer
Sold on a plan
$485.43K 13,425 at 36.16
10.3%
Planned (10b5-1)
Showing 39,101–39,150 of 60,176. ← Newer Page 783 of 1,204 Older →